540 related articles for article (PubMed ID: 18813109)
21. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
Newell KA; He G; Guo Z; Kim O; Szot GL; Rulifson I; Zhou P; Hart J; Thistlethwaite JR; Bluestone JA
J Immunol; 1999 Sep; 163(5):2358-62. PubMed ID: 10452966
[TBL] [Abstract][Full Text] [Related]
22. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
[TBL] [Abstract][Full Text] [Related]
23. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
Schilbach K; Schick J; Wehrmann M; Wollny G; Simon P; Schlegel PG; Eyrich M
Transplantation; 2007 Jul; 84(2):214-22. PubMed ID: 17667813
[TBL] [Abstract][Full Text] [Related]
24. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
25. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
[TBL] [Abstract][Full Text] [Related]
26. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
[TBL] [Abstract][Full Text] [Related]
27. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
29. Acute rejection of vascular heart allografts by perforin-deficient mice.
Schulz M; Schuurman HJ; Joergensen J; Steiner C; Meerloo T; Kägi D; Hengartner H; Zinkernagel RM; Schreier MH; Bürki K
Eur J Immunol; 1995 Feb; 25(2):474-80. PubMed ID: 7533086
[TBL] [Abstract][Full Text] [Related]
30. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
[TBL] [Abstract][Full Text] [Related]
31. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
[TBL] [Abstract][Full Text] [Related]
32. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
[TBL] [Abstract][Full Text] [Related]
33. The role of donor and recipient B7-1 (CD80) in allograft rejection.
Zheng XX; Sayegh MH; Zheng XG; Li Y; Linsley PS; Peach R; Borriello F; Strom TB; Sharpe AH; Turka LA
J Immunol; 1997 Aug; 159(3):1169-73. PubMed ID: 9233610
[TBL] [Abstract][Full Text] [Related]
34. Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice.
Kasagi S; Kawano S; Okazaki T; Honjo T; Morinobu A; Hatachi S; Shimatani K; Tanaka Y; Minato N; Kumagai S
J Immunol; 2010 Mar; 184(5):2337-47. PubMed ID: 20139271
[TBL] [Abstract][Full Text] [Related]
35. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
[TBL] [Abstract][Full Text] [Related]
36. PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice.
Ma D; Duan W; Li Y; Wang Z; Li S; Gong N; Chen G; Chen Z; Wan C; Yang J
PLoS One; 2016; 11(3):e0152087. PubMed ID: 26990974
[TBL] [Abstract][Full Text] [Related]
37. The function of donor versus recipient programmed death-ligand 1 in corneal allograft survival.
Shen L; Jin Y; Freeman GJ; Sharpe AH; Dana MR
J Immunol; 2007 Sep; 179(6):3672-9. PubMed ID: 17785803
[TBL] [Abstract][Full Text] [Related]
38. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T-cells.
Grazia TJ; Plenter RJ; Doan AN; Kelly BP; Weber SM; Kurche JS; Cushing SO; Gill RG; Pietra BA
Transplantation; 2007 Jun; 83(11):1449-58. PubMed ID: 17565318
[TBL] [Abstract][Full Text] [Related]
40. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
